The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy
Not Applicable
Terminated
- Conditions
- Contrast Induced Nephropathy
- Registration Number
- NCT00494637
- Lead Sponsor
- Lenox Hill Hospital
- Brief Summary
Preliminary studies have shown a benefit of sodium bicarbonate infusion in decreasing the risk of contrast induced nephropathy with coronary angiography. The investigators plan to randomize 478 patients (with serum creatinine 1.5 mg/dl or greater) undergoing coronary angiography to intravenous isotonic saline or intravenous isotonic sodium bicarbonate beginning one hour before the procedure and for four hours after. The primary endpoint is the development of contrast nephropathy within 48-72 hours after the procedure. Patients with an ejection fraction \<30%, overt CHF, hypokalemia and alkalemia will be excluded.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 468
Inclusion Criteria
- serum creatinine greater then or equal to 1.5
Exclusion Criteria
- EF<30
- Overt CHF
- Alkalemia
- Hypokalemia
- GFR<20 cc/min
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Incidence of contrast induced nephropathy 48-72 hours
- Secondary Outcome Measures
Name Time Method